humanitarian

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Zumrad, sasanlimab, Status: Application withdrawn

Reported by EMA What Is New Sep 15, 2026 · 13:10 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

6 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 32, Status: Authorised13:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 32, Status: Authorised13:10 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised13:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised13:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: Authorised12:42 UTC

INCIDENT EVOLUTION

4 recorded states

Sep 15 · 13:15 UTC

Signal first indexedP2 · 99% quality · 2 sources

Sep 15 · 13:16 UTC

Headline updatedP2 · 99% quality · 2 sources

Sep 15 · 13:50 UTC

Source details updatedP2 · 99% quality · 2 sources

Sep 15 · 13:51 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →